Edition:
United States

Medigus Ltd (MDGS.OQ)

MDGS.OQ on NASDAQ Stock Exchange Capital Market

1.30USD
15 Dec 2017
Change (% chg)

$-0.04 (-2.99%)
Prev Close
$1.34
Open
$1.34
Day's High
$1.34
Day's Low
$1.25
Volume
4,977
Avg. Vol
10,664
52-wk High
$10.60
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Medigus Q3 revenue falls 14 percent to $117,000
Friday, 24 Nov 2017 07:53am EST 

Nov 24 (Reuters) - Medigus Ltd :Medigus announces third quarter 2017 financial results.Q3 revenue fell 14 percent to $117,000.  Full Article

Medigus announces second quarter 2017 financial results
Monday, 18 Sep 2017 04:05pm EDT 

Sept 18 (Reuters) - Medigus Ltd :Medigus announces second quarter 2017 financial results.Medigus Ltd - ‍operating loss for three months ended June 30, 2017, was $1.3 million, compared to $2.7 million in three months ended June 30, 2016​.Medigus Ltd - Revenues for three months ended June 30, 2017, were $82,000, a decrease of 16%, compared to three months ended June 30, 2016.  Full Article

Medigus broadens availability of MUSE device via deal
Wednesday, 26 Jul 2017 07:22am EDT 

July 26 (Reuters) - Medigus Ltd :Medigus broadens availability of muse(tm) through distribution agreement with admedics ag in switzerland and liechtenstein.Medigus ltd - announced a distribution agreement in switzerland and liechtenstein with admedics ag.Medigus ltd - commercialization agreement will take effect july 1, 2017.Medigus ltd - admedics ag required to purchase minimum of eur 1.8 million of medigus ultrasonic surgical endostapler equipment over course of 5 year agreement.  Full Article

Medigus expands distribution arrangement with Golden Grand in China
Tuesday, 18 Jul 2017 08:34am EDT 

July 18 (Reuters) - Medigus Ltd ::Says expands distribution arrangement with Golden Grand in China.Medigus Ltd - Golden Grand has committed to minimum purchase of $27 million worth of muse system over five years, from the date of CFDA approval.Medigus Ltd - expanded agreement terms replace former agreement, which included minimum purchase of $17 million worth of systems over four years.  Full Article

Empery Asset Management reports 9.99 percent passive stake in Medigus Ltd as of March 24
Monday, 27 Mar 2017 02:54pm EDT 

Empery Asset Management LP :Empery Asset Management LP reports a 9.99 percent passive stake in Medigus Ltd as of March 24, 2017 - sec filing.  Full Article

Medigus says auditors have expressed substantial doubt about ability to continue as a going concern - SEC Filing
Monday, 27 Mar 2017 11:38am EDT 

Medigus Ltd :Auditors have expressed substantial doubt about ability to continue as a going concern, which may hinder ability to obtain further financing - SEC Filing.  Full Article

Medigus receives approval to conduct multi-center muse clinical study in China
Thursday, 16 Feb 2017 07:00am EST 

Medigus Ltd - : Medigus receives approval for commencement of the first multi-center muse clinical study from cfda in China .Procedures are expected to start in march and carry on through 2017, with results being reported to cfda in 2018 from muse clinical study.  Full Article

Medigus expands commercial availability of MUSE through distribution agreement with Innovamedica S.P.A. in Italy
Tuesday, 22 Nov 2016 04:05pm EST 

Medigus Ltd : Medigus expands global commercial availability of MUSE™ through distribution agreement with Innovamedica S.P.A. in Italy; new agreement broadens medigus’ accessibility in key markets around the world .Medigus - Innovamedica S.P.A. will be required to purchase at least EUR 1 million of Medigus ultrasonic surgical endostapler equipment over course of deal.  Full Article

Medigus CFO Gilad Mamlok to leave the company
Thursday, 17 Nov 2016 04:35pm EST 

Medigus Ltd : Gilad Mamlok, the chief financial officer of the company, will leave the company at the end of January 2017 .Oded Yatzkan will be appointed as the company's chief financial officer Upon Mamlok's termination.  Full Article

Medigus announces second quarter 2016 financial results
Wednesday, 31 Aug 2016 04:05pm EDT 

Medigus Ltd :Announces second quarter 2016 financial results.  Full Article

BRIEF-Medigus Q3 revenue falls 14 percent to $117,000

* Q3 revenue fell 14 percent to $117,000 Source text for Eikon: Further company coverage: